What does D-MEDICAL do?

D-MEDICAL is a commercial agency in Schilde. Private Limited, started on 14 January 2008, 1 establishment.

What is the address of D-MEDICAL?

The registered office of D-MEDICAL is located at Turnhoutsebaan 14, 2970 Schilde.

Is D-MEDICAL still active?

Yes. According to the CBE (1 October 2026) D-MEDICAL is active, legal situation “Normale toestand”, started on 14 January 2008.

Is D-MEDICAL registered on Peppol?

Yes, D-MEDICAL is registered on the Peppol network with ID 0208:0894880923.

What is the enterprise number of D-MEDICAL?

The enterprise number of D-MEDICAL is BE0894880923.

When was D-MEDICAL founded?

D-MEDICAL was founded on 14 January 2008.

Who are the directors of D-MEDICAL?

According to the 2024 annual accounts, the directors of D-MEDICAL are: Dylan VANHOLME.

Is D-MEDICAL a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 14 January 2008; 4 annual accounts filed, latest fiscal year 2024; 1 directors known from the annual account.

How much profit did D-MEDICAL make in 2024?

D-MEDICAL posted a profit after taxes of € 845 in financial year 2024.

What is the revenue of D-MEDICAL?

As a small company, D-MEDICAL is not required to publish revenue in its annual accounts. In financial year 2024, its added value was € 16,359.

How many employees does D-MEDICAL have?

According to the 2024 annual accounts, D-MEDICAL has 0 full-time equivalents (FTE).

D-MEDICAL (Private Limited) - Schilde - BE0894880923

Dossier D-MEDICAL, printed on 1 October 2026 from databakkes.be/en/0894880923/d-medical. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Tight liquidity NBB

Cash and receivables cover 47 % of short-term debt in 2024; threshold 65 %.

Financials

Financial year 2024

D-MEDICAL from Schilde, company number BE0894880923, closed financial year 2024 with a result of € 845 after tax. For that financial year D-MEDICAL recorded a gross margin of € 16,359 and equity of € 27,012. Compared with financial year 2023, the result moved from € 974 to € 845. The company is profitable. The buffer is growing. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on August 29, 2025.

What it is worth Growing

€ 27,012

▲ 3% vs 2023

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 845

▼ 13% vs 2023

Profit after tax over the fiscal year.

Cash in the bank

€ 5,857

▼ 2% vs 2023

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2024. Retained profit grew to € -6,588.

People and assets in 2024

Full-time equivalents

Average over the fiscal year, from the social balance sheet.

Debts at end 2024

Bank debt ≈ 5 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 248,094

▼ 16% vs 2023

€ 48,350 is repaid this year. At this pace the long-term loan is gone in ≈ 5 years.

Owed to suppliers

€ 19,939

▼ 13% vs 2023

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 7,672

▲ 33% vs 2023

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2021	2022	2023	2024	Change 2023 → 2024
Gross margin	€ 30,746 Gross margin 2021: € 30,746 First fiscal year in the series	€ 22,261 Gross margin 2022: € 22,261 ▼ 28% vs 2021 (€ 30,746) Unfavourable step	€ 24,854 Gross margin 2023: € 24,854 ▲ 12% vs 2022 (€ 22,261) Favourable step	€ 16,359 Gross margin 2024: € 16,359 ▼ 34% vs 2023 (€ 24,854) Unfavourable step	▼ 34%
Profit after taxes	€ 17,810 Profit after taxes 2021: € 17,810 First fiscal year in the series	€ 5,596 Profit after taxes 2022: € 5,596 ▼ 69% vs 2021 (€ 17,810) Unfavourable step	€ 974 Profit after taxes 2023: € 974 ▼ 83% vs 2022 (€ 5,596) Unfavourable step	€ 845 Profit after taxes 2024: € 845 ▼ 13% vs 2023 (€ 974) Unfavourable step	▼ 13%
Equity	€ 19,597 Equity 2021: € 19,597 First fiscal year in the series	€ 25,193 Equity 2022: € 25,193 ▲ 29% vs 2021 (€ 19,597) Favourable step	€ 26,167 Equity 2023: € 26,167 ▲ 4% vs 2022 (€ 25,193) Favourable step	€ 27,012 Equity 2024: € 27,012 ▲ 3% vs 2023 (€ 26,167) Favourable step	▲ 3%
Total debts	€ 40,133 Total debts 2021: € 40,133 First fiscal year in the series	€ 382,511 Total debts 2022: € 382,511 ▲ € 342,378 vs 2021 (€ 40,133) Unfavourable step	€ 378,559 Total debts 2023: € 378,559 ▼ 1% vs 2022 (€ 382,511) Favourable step	€ 431,656 Total debts 2024: € 431,656 ▲ 14% vs 2023 (€ 378,559) Unfavourable step	▲ 14%
Cash	€ 17,072 Cash 2021: € 17,072 First fiscal year in the series	€ 7,299 Cash 2022: € 7,299 ▼ 57% vs 2021 (€ 17,072) Unfavourable step	€ 5,977 Cash 2023: € 5,977 ▼ 18% vs 2022 (€ 7,299) Unfavourable step	€ 5,857 Cash 2024: € 5,857 ▼ 2% vs 2023 (€ 5,977) Unfavourable step	▼ 2%
Retained profit	€ -14,003 Retained profit 2021: € -14,003 First fiscal year in the series	€ -8,407 Retained profit 2022: € -8,407 ▲ € 5,596 vs 2021 (€ -14,003) Favourable step	€ -7,433 Retained profit 2023: € -7,433 ▲ € 974 vs 2022 (€ -8,407) Favourable step	€ -6,588 Retained profit 2024: € -6,588 ▲ € 845 vs 2023 (€ -7,433) Favourable step	▲ € 845
Bank debt	€ 0 Bank debt 2021: € 0 First fiscal year in the series	€ 339,129 Bank debt 2022: € 339,129 Unchanged (€ 0) Unfavourable step	€ 294,530 Bank debt 2023: € 294,530 ▼ 13% vs 2022 (€ 339,129) Favourable step	€ 248,094 Bank debt 2024: € 248,094 ▼ 16% vs 2023 (€ 294,530) Favourable step	▼ 16%
Balance sheet total	€ 59,730 Balance sheet total 2021: € 59,730 First fiscal year in the series	€ 407,704 Balance sheet total 2022: € 407,704 ▲ € 347,974 vs 2021 (€ 59,730) Unchanged	€ 404,725 Balance sheet total 2023: € 404,725 ▼ 1% vs 2022 (€ 407,704) Unchanged	€ 458,668 Balance sheet total 2024: € 458,668 ▲ 13% vs 2023 (€ 404,725) Unchanged	▲ 13%

Key figures of D-MEDICAL, fiscal years 2021 to 2024, from the annual accounts filed with the National Bank of Belgium.The annual account for fiscal year 2025 has not been filed yet; it was expected before 31 July 2026.

What happened to D-MEDICAL?

What happened at D-MEDICAL in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Aug 29, 2025 New annual accounts for financial year 2024: profit of € 845 (▼ 13% vs 2023). filed late Source: NBB ↗
2021 Dylan VANHOLME became a director. NBB
Jan 14, 2008 Start of the company according to the CBE. KBO
Jan 8, 2008 New establishment in Schilde. KBO

In short

From € 17,810 profit in 2021 to € 845 profit in 2024.

Paid € 19,283 in corporate taxes since 2021.

Best year ever: 2021, with € 17,810 profit.

Original PDFs at the National Bank ↗

A new publication or filing at D-MEDICAL? We notify you, reason included.

Follow D-MEDICAL

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Dylan Vanholme

D-MEDICAL

DJ Medical 98%

Behind D-MEDICAL is Dylan VANHOLME. The shares are held by Dylan Vanholme. It owns 98% of DJ Medical itself.

See the full network in the app

Directors

According to the 2024 annual accounts

Dylan VANHOLME

Director

Is a shareholder

Also active at: DJ MEDICAL

since 2021

Shareholders

Dylan Vanholme · director

Participations

DJ Medical

98%

Establishments

Establishment units

Physical locations of this company

Registered office

Turnhoutsebaan 14

2970 Schilde

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

DJ MEDICAL same network

€ 74,039 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0894.880.923

VAT number

BE 0894.880.923

Registered office

Turnhoutsebaan 14, 2970 Schilde

Names & denominations

D-MEDICAL

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

14 January 2008

Peppol

Active · Active since 12 Feb 2025

Contact

[email protected]

Activities · NACE

Handelsbemiddeling in de niet-gespecialiseerde groothandel

Schoonheidsverzorging en andere schoonheidsbehandelingen

Schoonheidsverzorging

View on CBE Public ↗ Annual accounts (NBB) ↗

D-MEDICAL

Warning lights

Financials

What happened to D-MEDICAL?

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions